Conteduca, V.; Caffo, O.; Scarpi, E.; Sepe, P.; Galli, L.; Fratino, L.; Maines, F.; Chiuri, V.E.; Santoni, M.; Zanardi, E.;
et al. Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy. J. Clin. Med. 2020, 9, 1950.
https://doi.org/10.3390/jcm9061950
AMA Style
Conteduca V, Caffo O, Scarpi E, Sepe P, Galli L, Fratino L, Maines F, Chiuri VE, Santoni M, Zanardi E,
et al. Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy. Journal of Clinical Medicine. 2020; 9(6):1950.
https://doi.org/10.3390/jcm9061950
Chicago/Turabian Style
Conteduca, Vincenza, Orazio Caffo, Emanuela Scarpi, Pierangela Sepe, Luca Galli, Lucia Fratino, Francesca Maines, Vincenzo Emanuele Chiuri, Matteo Santoni, Elisa Zanardi,
and et al. 2020. "Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy" Journal of Clinical Medicine 9, no. 6: 1950.
https://doi.org/10.3390/jcm9061950
APA Style
Conteduca, V., Caffo, O., Scarpi, E., Sepe, P., Galli, L., Fratino, L., Maines, F., Chiuri, V. E., Santoni, M., Zanardi, E., Massari, F., Toma, I., Lolli, C., Schepisi, G., Sbrana, A., Kinspergher, S., Cursano, M. C., Casadei, C., Modonesi, C.,
... De Giorgi, U.
(2020). Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy. Journal of Clinical Medicine, 9(6), 1950.
https://doi.org/10.3390/jcm9061950